Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,859,413 papers from all fields of science
Search
Sign In
Create Free Account
gemcitabine-oxaliplatin regimen
Known as:
GEM-OX Regimen
, GEMOX Regimen
A regimen consisting of gemcitabine and oxaliplatin used for the treatment of biliary adenocarcinoma, pancreatic cancer, hepatocellular cancer and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Broader (3)
Antineoplastic Combined Chemotherapy Protocols
Deoxycytidine
Organoplatinum Compounds
Gemcitabine hydrochloride
Pancreatic carcinoma
analogs & derivatives
oxaliplatin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Clinical analysis of 36 patients with nasal extranodal natural killer/T cell lymphoma treated by P-Gemox regimen combined with radiotherapy
Can Liu
,
Jingyi Zhang
,
Jing Gao
,
Yi Chen
2019
Corpus ID: 219848644
Objective To explore the clinical therapeutic effects, prognosis and influencing factors of patients with nasal extranodal…
Expand
Review
2014
Review
2014
Observation of GEMOX regimen combined with endostar as the first-line treatment for patients with advanced biliary tract carcinoma
Liang Ron
2014
Corpus ID: 75307399
Objective To observe the efficacy and safety of endostar combined with gemcitabine and oxaliplatin as the firstline treatment for…
Expand
2014
2014
Study of the efficacy and safety of GEMOX regimen for the patients with advanced primary liver cancer
Liang Hai-ta
2014
Corpus ID: 75439139
Objective To investigate the efficacy and safety of gemcitabine(GEM) combined with oxaliplatin(OX) in the treatment of the…
Expand
2012
2012
Comparison of Fixed-dose Rate Gemcitabine Infusion Combined with Oxaliplatin and Routine GEMOX Regimen in Treatment of Patients with Advanced Hepatocellular Carcinoma
Huang Zhen-zhen
2012
Corpus ID: 75380503
Objective:To Compare efficiency and toxicity of Fixed-dose Rate Gemcitabine Infusion Combined with Oxaliplatin and routine GEMOX…
Expand
2011
2011
Clinical Study of Thalidomide Combined with GEMOX regimen for Advanced Hepatocellular Carcinoma
L. Xia
2011
Corpus ID: 75298964
Objective To observe the clinical efficacy and safety of thalidomide combined with gemcitabine and oxaliplatin(GEMOX regimen) for…
Expand
2011
2011
Clinical outcomes of GEMOX regimen in treatment of patients with advanced pancreatic cancer
Su Jin
2011
Corpus ID: 77000661
Objective To evaluate the efficacy and toxicity of GEMOX regimen in treatment of the patients with advanced pancreatic cancer…
Expand
2010
2010
Preliminary results of a phase II study of rituximab (R), gemcitabine (Gem), oxaliplatin (Ox) plus enzastaurin (ENZ) followed by ENZ maintenance as salvage regimen for patients with relapsed or…
C. Haioun
,
F. Morschhauser
,
+6 authors
M. Hahka‐Kemppinen
2010
Corpus ID: 73793939
8069 Background: PKC overexpression is observed in relapsed/refractory DLBCL. Enzastaurin (ENZ), an oral serine/threonine kinase…
Expand
2010
2010
Rituximab plus gemcitabine and oxaliplatine (R-GemOx) in refractory/relapsed patients with diffuse large B-cell lymphoma (DLBCL) who are not candidates for high-dose therapy (HDT): A GELA study.
T. E. Gnaoui
,
H. Tilly
,
+7 authors
C. Haioun
2010
Corpus ID: 73785262
8011 Background: We conducted a multi-center phase II trial using R-GemOx: R (375mg/m2, d1), Gem (1,000 mg/m2,d2) and Ox (100 mg…
Expand
2008
2008
An initial study of GEMOX regimen for the patients with advanced hepatocellular carcinoma
Sun Xiaoqin
2008
Corpus ID: 75252034
Objective:To observe the efficiency and safety of gemeitabin combined with oxaliplatin in treating the patients with…
Expand
2005
2005
Clinic study on efficacy of GEMOX regimen in patients with advanced pancreatic cancer
M. Dong
2005
Corpus ID: 75975347
OBJECTIVE: To observe the efficacy and toxicity of Gemcitabine plus Oxaliplatin combination regimen on patients with advanced…
Expand